| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
| 01/18/2000 | US6015800 Substituted quinoxaline-2-ones as glutamate receptor antagonists |
| 01/18/2000 | US6015774 Pyrazin-2-one derivatives, their use, and intermediates for their production |
| 01/18/2000 | CA2012506C Azo compounds containing hindered amine moieties with low basicity |
| 01/18/2000 | CA2012493C 1-hydrocarbyloxy hindered amine mercaptoacid esters, thioacetals, sulfides and disulfides |
| 01/13/2000 | WO2000001678A1 Process for the synthesis of substituted piperazinones via mitsunobu reaction |
| 01/13/2000 | WO2000001677A1 Piperazine derivatives inhibiting human immunodeficiency virus replication |
| 01/13/2000 | WO2000001376A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 01/13/2000 | WO2000001375A2 Calcium channel blockers |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | CA2337059A1 Piperazine derivatives inhibiting human immunodeficiency virus replication |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0969823A2 Anti-epileptogenic agents |
| 01/11/2000 | US6013836 Insecticidal N'-substituted-N,N'-disubstitutedhydrazines |
| 01/11/2000 | CA2195027C Hiv protease inhibitors useful for the treatment of aids |
| 01/06/2000 | WO2000000478A1 Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2334332A1 Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 01/05/2000 | EP0968250A1 Soluble chromophores having improved solubilising groups |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968201A2 New aminopiperazine derivatives |
| 01/05/2000 | EP0968175A1 Spiro compounds and the use thereof |
| 01/05/2000 | EP0968171A1 Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 01/05/2000 | CN1240430A Bis(acridinecarboxamide) and Bis(phenazinecarboxamide) as antitumour agents |
| 01/05/2000 | CN1240419A Aromatic amine derivatives having NOS inhibitory effect |
| 01/04/2000 | US6011035 Libraries of these compounds can also be used to identify antagonists for other targets. compounds containing benzhydril and 6-membered heterocyclic moieties |
| 12/29/1999 | WO1999067231A1 Nitrate salts of antihypertensive medicines |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | EP0966490A2 Catalyst compositions for the polymerization of olefins |
| 12/29/1999 | EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 12/29/1999 | EP0966454A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 12/29/1999 | EP0966448A1 Pyrazine compounds |
| 12/29/1999 | EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 12/29/1999 | EP0612314B1 2-pyrazinylethylamine derivatives and their use as pharmaceuticals |
| 12/29/1999 | CA2335356A1 Nitrate salts of antihypertensive medicines |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis |
| 12/23/1999 | WO1999065922A2 Prenyl transferase inhibitors |
| 12/23/1999 | WO1999065871A2 Thiolesters and uses thereof |
| 12/23/1999 | WO1999065870A2 Sulfonamide inhibitors of aspartyl protease |
| 12/23/1999 | CA2337603A1 Prenyl transferase inhibitors |
| 12/23/1999 | CA2335464A1 Novel thiolesters and uses thereof |
| 12/22/1999 | EP0733033B1 Pharmaceutically active substituted aromatic compounds |
| 12/22/1999 | EP0674628B1 Chemopreventive compounds and a preparation method and use thereof |
| 12/22/1999 | CN1239473A Method of preparing amino carboxylic acids |
| 12/21/1999 | CA2065842C Process for inactivating viruses in blood and blood products |
| 12/21/1999 | CA2001171C Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
| 12/16/1999 | WO1999064422A1 Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | WO1999064041A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | WO1999064039A1 Bradykinin antagonists |
| 12/16/1999 | WO1999064038A1 Novel analgesic agents |
| 12/16/1999 | WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | WO1999063999A1 H1-histamine receptor antagonists |
| 12/16/1999 | WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 12/16/1999 | WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors |
| 12/16/1999 | WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors |
| 12/16/1999 | WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 12/16/1999 | WO1999063930A2 Novel angiotensin receptor modulators and their uses |
| 12/16/1999 | CA2334671A1 Pyrido¬2,3-b|indolizine derivatives and aza analogues thereof; crf1 specific ligands |
| 12/16/1999 | CA2321273A1 Novel analgesic agents |
| 12/16/1999 | CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | CA2321152A1 Novel therapeutic agents that modulate endothelin receptors |
| 12/16/1999 | CA2321120A1 .beta.3-adrenergic receptor agonists |
| 12/16/1999 | CA2320926A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | CA2319730A1 Bradykinin antagonists |
| 12/16/1999 | CA2319651A1 H1-histamine receptor antagonists |
| 12/16/1999 | CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | CA2319497A1 Novel therapeutic agents that modulate estrogen receptors |
| 12/16/1999 | CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 12/16/1999 | CA2319175A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | CA2319068A1 Novel angiotensin receptor modulators and their uses |
| 12/16/1999 | CA2318894A1 .beta.2-adrenergic receptor agonists |
| 12/16/1999 | CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors |
| 12/16/1999 | CA2318055A1 .beta.2-adrenergic receptor agonists |
| 12/15/1999 | EP0963372A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists |
| 12/15/1999 | EP0685457B1 Glycerol derivative, device and pharmaceutical composition |
| 12/14/1999 | US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent |
| 12/14/1999 | US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use |
| 12/14/1999 | US6001330 Diamine dopamine or serotonin ligand of given formula; labeled with a radionuclide and administered for imaging dopamine neurons in a mammal; treating cocaine abuse |
| 12/09/1999 | WO1999062968A1 Supported group 8-10 transition metal olefin polymerization catalysts |
| 12/09/1999 | WO1999062887A1 Cyanoiminoquinoxaline derivatives |
| 12/09/1999 | WO1999062520A1 Hiv integrase inhibitors |
| 12/09/1999 | WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/09/1999 | WO1999062487A1 Heterocyclic ester and amide hair growth compositions and uses |
| 12/09/1999 | DE19924984A1 Compositions stabilized against degradation by light, oxidation and/or heat |
| 12/09/1999 | CA2334204A1 Heterocyclic ester and amide hair growth compositions and uses |
| 12/09/1999 | CA2333768A1 Supported group 8-10 transition metal olefin polymerization catalysts |